SCHEMBL17713985

SCHEMBL17713985

O=C(O)C1Cc2cc(O)c(O)cc2C(Cc2ccccc2)N1

nearest known ligand 0.56

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 5/20 0.56
KDM1A O60341 2/20 0.54
DRD2 P14416 2/20 0.44
DRD4 P21917 2/20 0.44
TBXA2R P21731 6/20 0.42
MEN1 O00255 1/20 0.41
ABL1 P00519 1/20 0.41
ALPL P05186 1/20 0.41
GAA P10253 1/20 0.41
KMT2A Q03164 1/20 0.41
RIN1 Q13671 1/20 0.41
ADRB1 P08588 1/20 0.41
FYN P06241 1/20 0.40
CACNA1G O43497 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17725672 1.00 ADRB2 (0.56) ADRB2KDM1ADRD2DRD4TBXA2R
SCHEMBL17713982 0.91 KDM1A (0.55) ADRB2KDM1ADRD2DRD4TBXA2R
SCHEMBL17713956 0.87 MAPT (0.46) ADRB2KDM1AGAAFYN
SCHEMBL17725771 0.87 MAPT (0.46) ADRB2KDM1AGAAFYN
SCHEMBL5319112 0.83 SLC22A1 (0.50) ADRB2KDM1AMEN1GAAKMT2A
SCHEMBL17725791 0.83 ADRB2 (0.38) ADRB2KDM1ATBXA2RGAA
SCHEMBL17713979 0.83 ADRB2 (0.38) ADRB2KDM1ATBXA2RGAA
SCHEMBL17713968 0.82 ADRB2 (0.50) ADRB2TBXA2RMEN1ABL1ALPL
SCHEMBL17725635 0.82 ADRB2 (0.50) ADRB2TBXA2RMEN1ABL1ALPL
SCHEMBL17713948 0.81 ADRB2 (0.49) ADRB2DRD2TBXA2RMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104161758-A Applications of tetrahydroisoquinoline-3-carboxylic acid derivatives in preparation of medicines treating dopaminergic nerve diseases UNIV SOOCHOW 2014-11-26 CN claimed
CN-104161758-B 3 carboxylic acid tetrahydro isoquinoline derivatives are preparing the application in treating dopaminergic nerve disease medicament 苏州大学 2018-01-02 CN disclosed
WO-2016065425-A1 BIOTRANSFORMATION REACTIONS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2016-05-06 WO disclosed
CN-104161758-A Applications of tetrahydroisoquinoline-3-carboxylic acid derivatives in preparation of medicines treating dopaminergic nerve diseases UNIV SOOCHOW 2014-11-26 CN disclosed